TD Cowen Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $360
Piper Sandler Maintains Amgen(AMGN.US) With Buy Rating, Maintains Target Price $344
Jefferies Adjusts Price Target on Amgen to $380 From $375
Amgen Analyst Ratings
Morgan Stanley Adjusts Price Target on Amgen to $303 From $310
Amgen Analyst Ratings
Amgen Analyst Ratings
Research Alert: CFRA Adds Amgen Inc. To The High-quality Capital Appreciation Portfolio
Barclays Sticks to Its Hold Rating for Amgen (AMGN)
HSBC Adjusts Price Target on Amgen to $356 From $322
Redburn Adjusts Price Target on Amgen to $170 From $180, Keeps Sell Rating
Amgen Analyst Ratings
Redburn Atlantic Adjusts Price Target on Amgen to $180 From $170
Mizuho Securities Raises Amgen's Price Target to $235 From $223
Amgen Analyst Ratings
RBC Capital Reaffirms Their Buy Rating on Amgen (AMGN)
Morgan Stanley Adjusts Price Target on Amgen to $310 From $271, Keeps Equalweight Rating
Amgen Analyst Ratings
Amgen Analyst Ratings
Amgen Analyst Ratings